|Bid||47.68 x 800|
|Ask||47.73 x 900|
|Day's Range||47.34 - 48.36|
|52 Week Range||41.61 - 59.00|
|Beta (5Y Monthly)||0.24|
|PE Ratio (TTM)||25.07|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
QGEN earnings call for the period ending March 31, 2021.
QIAGEN's (QGEN) first-quarter 2021 revenues improved year over year on strong demand for product groups addressing the critical demand for COVID-19 testing.
View more earnings on CVSSee more from BenzingaClick here for options trades from BenzingaPremier Beats On Q3 Earnings, Raises 2021 OutlookQiagen Q1 Earnings Tops Estimates As Growth In Non-COVID-19 Products Boost Revenues© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.